Editas Medicine, Inc. Contracts & Agreements
69 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (7)
- Human Resources (27)
- Intellectual Property (8)
- Real Estate (1)
- Uncategorized (14)
- Omnibus Amendment, dated as of February 5, 2024, by and among the Registrant, Broad and Harvard (Filed With SEC on February 28, 2024)
- Summary of Director Compensation Program (Filed With SEC on February 28, 2024)
- Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 28, 2024)
- Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 28, 2024)
- Form of Restricted Stock Unit Award Agreement under the 2015 Stock Incentive Plan (Filed With SEC on February 28, 2024)
- Form of Restricted Stock Agreement under 2015 Stock Incentive Plan (Filed With SEC on February 28, 2024)
- Form of Nonstatutory Stock Option Agreement under 2015 Stock Incentive Plan (Filed With SEC on February 28, 2024)
- Form of Incentive Stock Option Agreement under 2015 Stock Incentive Plan (Filed With SEC on February 28, 2024)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 28, 2024)
- Amended and Restated Severance Benefits Plan (Filed With SEC on November 22, 2023)
- Employment Offer Letter, dated May 12, 2023, between the Registrant and Erick Lucera (Filed With SEC on August 2, 2023)
- Separation Agreement, dated May 16, 2023, between the Registrant and Michelle Robertson (Filed With SEC on August 2, 2023)
- Employment Offer Letter, dated July 3, 2023, between the Registrant and Linda C. Burkly (Filed With SEC on August 2, 2023)
- Underwriting Agreement, June 14, 2023, by and among the Company, J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group, L.L.C (Filed With SEC on June 15, 2023)
- First Amendment to Lease Agreement, dated November 15, 2022 between Registrant and ARE-MA Region No. 55, LLC (Filed With SEC on February 22, 2023)
- Amendment to RSU Agreement, dated May 24, 2022, between the Registrant and James C. Mullen (Filed With SEC on August 3, 2022)
- Employment Offer Letter, dated June 14, 2022, between the Registrant and Baisong Mei (Filed With SEC on August 3, 2022)
- Amendment to Employment Offer Letter, dated April 13, 2022, between the Registrant and James C. Mullen (Filed With SEC on August 3, 2022)
- Employment Offer Letter, dated April 13, 2022, between the Registrant and Gilmore ONeill (Filed With SEC on August 3, 2022)
- Amended Severance Benefits Plan (Filed With SEC on February 24, 2022)
- Second Amendment to the Exclusive Patent License Agreement, by and between the Company and The General Hospital Corporation, d/b/a Massachusetts General Hospital, dated November... (Filed With SEC on November 9, 2021)
- License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc (Filed With SEC on November 9, 2021)
- License Agreement, dated October 29, 2014, among the Registrant, the President and Fellows of Harvard College, and the Broad Institute, Inc (Filed With SEC on November 9, 2021)
- Letter Agreement, dated October 9, 2015, between the Registrant and Duke University (Filed With SEC on November 9, 2021)
- License Agreement, dated October 10, 2014, between the Registrant and Duke University (Filed With SEC on November 9, 2021)
- License Agreement, dated August 29, 2014, between the Registrant and The General Hospital Corporation, d/b/a Massachusetts General Hospital (Filed With SEC on November 9, 2021)
- Employment Offer Letter, dated September 22, 2021, between the Registrant and Bruce Eaton (Filed With SEC on November 9, 2021)
- Employment Offer Letter, dated April 19, 2021, between the Registrant and Mark S. Shearman (Filed With SEC on August 5, 2021)
- Summary of Non-Employee Director Compensation Program (Filed With SEC on August 5, 2021)
- Common Stock Sales Agreement, dated as of May 14, 2021, by and between the Company and Cowen and Company, LLC (Filed With SEC on May 14, 2021)
- Omnibus Amendment, dated as of January 11, 2021, by and between the Registrant and Broad (Filed With SEC on February 26, 2021)
- First Amendment to Sponsored Research Agreement, dated January 11, 2021, between the Registrant and Broad (Filed With SEC on February 26, 2021)
- Employment Offer Letter, dated September 25, 2020, between the Registrant and Lisa A. Michaels, M.D (Filed With SEC on February 26, 2021)
- Summary of Director Compensation Program (Filed With SEC on February 26, 2021)
- Employment Offer Letter, dated February 14, 2021, between the Registrant and James C. Mullen (Filed With SEC on February 26, 2021)
- Letter Agreement, dated February 15, 2021, by and between the Registrant and Cynthia Collins (Filed With SEC on February 26, 2021)
- Underwriting Agreement, dated January 20, 2021, by and among the Company, J.P. Morgan Securities LLC and Morgan Stanley & Co. LLC (Filed With SEC on January 21, 2021)
- Termination Agreement, dated August 5, 2020, by and between the Company and Allergan Sales, LLC (Filed With SEC on November 6, 2020)
- Advisory Services Agreement, Dated May 1, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
- Separation Agreement, dated as of April 30, 2020, by and between the Company and Judith Abrams (Filed With SEC on August 7, 2020)
- Underwriting Agreement, dated June 23, 2020, by and between the Company and the Underwriter (Filed With SEC on June 25, 2020)
- Common Stock Sales Agreement, dated as of May 15, 2020, by and between the Company and Cowen (Filed With SEC on May 15, 2020)
- Amended Severance Benefits Plan (Filed With SEC on February 26, 2020)
- Letter Agreement, dated as of December 16, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
- Form of Inducement Restricted Stock Unit Award Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
- Letter Agreement, dated as of November 18, 2019, by and among, the Registrant, Broad and Harvard (Filed With SEC on February 26, 2020)
- Form of Inducement Stock Option Agreement for the Registrants executive officers (Filed With SEC on February 26, 2020)
- Employment Offer Letter, dated December 27, 2019, between the Registrant and Michelle Robertson (Filed With SEC on February 26, 2020)
- Employment Offer Letter, dated October 11, 2019, between the Registrant and Judith R. Abrams, M.D (Filed With SEC on February 26, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 26, 2020)
- Second Amended and Restated License and Collaboration Agreement, dated November 11, 2019, between the Registrant and Juno Therapeutics, Inc. (Juno) (Filed With SEC on February 26, 2020)
- License and Agreement, dated November 11, 2019, between the Registrant and Juno (Filed With SEC on February 26, 2020)
- Letter Agreement, dated September 26, 2019, by and between the Registrant and Vic Myer, Ph.D (Filed With SEC on November 12, 2019)
- Offer Letter, dated August 6, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on November 12, 2019)
- Letter Agreement, dated January 19, 2019, by and between the Registrant and Katrine Bosley (Filed With SEC on May 8, 2019)
- Consulting Agreement, dated January 20, 2019, by and between the Registrant and Cynthia Collins (Filed With SEC on May 8, 2019)
- Co-Development and Commercialization Agreement, dated February 22, 2019, by and between the Registrant and Allergan Sales, LLC (Filed With SEC on May 8, 2019)
- Separation Agreement, by and between the Registrant and Gerald Cox, M.D., Ph.D (Filed With SEC on March 1, 2019)
- Form of Restricted Stock Unit Award Agreement under 2015 Stock Incentive Plan (Filed With SEC on January 22, 2019)
- License and Collaboration Agreement, dated May 26, 2015, between the Registrant and Juno Therapeutics, Inc (Filed With SEC on November 8, 2018)
- Sponsored Research Agreement, dated June 7, 2018, between the Registrant and The Broad Institute, Inc (Filed With SEC on August 7, 2018)
- Amended and Restated License and Collaboration Agreement, dated May 3, 2018, between the Registrant and Juno Therapeutics, Inc (Filed With SEC on August 7, 2018)
- Underwriting Agreement, dated December 5, 2017, by and among Editas Medicine, Inc. and Morgan Stanley & Co. LLC (Filed With SEC on December 7, 2017)
- First Amendment to License Agreement, dated September 1, 2017, between the Registrant and Duke University (Filed With SEC on November 8, 2017)
- Form of Restricted Stock Agreement under 2015 Stock Incentive Plan (Filed With SEC on November 8, 2017)
- 4,000,000 Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on March 17, 2017)
- FIRST AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT MGH Agreement No: A221317 (Filed With SEC on March 3, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. THE GENERAL HOSPITAL CORPORATION EXCLUSIVE... (Filed With SEC on November 9, 2016)
- [ ] Shares EDITAS MEDICINE, INC. COMMON STOCK, $0.0001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on January 25, 2016)
